Elequin Capital’s BioStem Technologies BSEM Stock Holding History

Elequin Capital’s Portfolio BSEM Stock Details BSEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$32.8K	Buy	+10,614	New	+$40.3K	﹤0.01%	429

Other funds holding BSEM

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Anson Funds Management Dallas, Texas $1.82B AUM 38.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

Ashton Thomas Private Wealth Scottsdale, Arizona $4.98B AUM 21.09% 1-Year Est. Return

Vanguard Global Advisers Malvern, Pennsylvania $225B AUM

Beaird Harris Wealth Management Dallas, Texas $1.55B AUM 10.67% 1-Year Est. Return

Elequin Capital's BSEM Position: Q3 2026 in Review

Elequin Capital opened a new position in BioStem Technologies (BSEM) in Q3 2026: 10,614 shares worth $32.8K. The stake represents ﹤0.01% of the portfolio and ranks #429 among its holdings.

19 funds tracked by Wall St. Rank hold BSEM as of Q3 2026.

Elequin Capital held 10,614 shares of BioStem Technologies worth $32.8K as of Q3 2026.
BioStem Technologies was a new Elequin Capital position in Q3 2026.
BioStem Technologies made up ﹤0.01% of Elequin Capital's portfolio in Q3 2026, its #429 holding.
19 funds tracked by Wall St. Rank held BioStem Technologies as of Q3 2026.

Based on Elequin Capital's 13F filing for Q3 2026, filed 13 Nov 2026.